BPLXKUR WART REMOVER BANDAID- salicylic acid patch

Drug Labeling and Warnings

Drug Details [pdf]

ACTIVE INGREDIENT

Salicylic acid 40%

PURPOSE

Wart remover

INDICATIONS & USAGE

for the removal of common warts
the common wart is easily recognized by the rough "cauliflower-like" appearance of the surface

WARNINGS

For external use only.

DO NOT USE

on irritated skin
oninfected or reddened areas
on moles
on birthmarks
on warts with hair growing from them
on genital wartson warts
on the face or mucous membranes
if you are a diabetic
if you have poor blood circulation

WHEN USING

avoid contact with eyes
do not apply to healthy surrounding skin
if product gets into eyes, flush thoroughly with water
mild discomfort or irritation may occur

STOP USE

if discomfort persists, see your doctor

if the wart remains after 12 weeks of treatment

KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION

wash affected area
may soak wart in warm water for 5 minutes
dry area thoroughly
apply medicated pad directly to wart
cover with adhesive bandage if needed
repeat procedure every 48 hours as needed (until wart is removed) for up to 12 weeks

INACTIVE INGREDIENT

Lanolin, Polybutene

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

BPLXKUR WART REMOVER BANDAID 
salicylic acid patch

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 85578-007
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	0.4 g

Inactive Ingredients
Ingredient Name	Strength
POLYBUTENE (1400 MW) (UNII: 1NA5AO9GH7)
LANOLIN (UNII: 7EV65EAW6H)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85578-007-01	14 in 1 BOX	04/09/2026
1		1 in 1 PATCH; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M028	04/09/2026

Labeler - Zhengzhou Hangrui Network Technology Co., Ltd. (700094663)

Establishment
Name	Address	ID/FEI	Business Operations
Zhengzhou Hangrui Network Technology Co., Ltd.		700094663	manufacture(85578-007)